-
公开(公告)号:US07144883B2
公开(公告)日:2006-12-05
申请号:US10167141
申请日:2002-06-11
申请人: Patrizia Caldirola , Gary Johansson , Andrew Mott , Katarina Beierlien , Markus Thor , Lars Tedenborg , Ulf Bremberg , Annika Jenmalm Jensen
发明人: Patrizia Caldirola , Gary Johansson , Andrew Mott , Katarina Beierlien , Markus Thor , Lars Tedenborg , Ulf Bremberg , Annika Jenmalm Jensen
IPC分类号: A61P3/04 , A61P7/00 , A61K31/42 , A61K31/445 , A61K31/497
CPC分类号: C07D295/096 , A61K31/495 , A61K31/4965 , C07D215/38 , C07D215/40 , C07D217/22 , C07D241/04 , C07D243/08 , C07D295/135 , C07D307/78 , C07D307/79 , C07D319/18 , C07D333/34 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08
摘要: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
摘要翻译: 本发明涉及通式(I)的取代磺酰胺化合物,其中P是磺酰胺或酰胺取代的磺酸,该化合物潜在地用于预防和治疗与肥胖,II型糖尿病和/或 中枢神经系统疾病
-
公开(公告)号:US07572787B2
公开(公告)日:2009-08-11
申请号:US11510324
申请日:2006-08-25
申请人: Patrizia Caldirola , Ulf Bremberg , Gary Johansson , Andrew Mott , Annika Jenmalm Jensen , Katarina Beierlien , Markus Thor , Lars Tedenborg
发明人: Patrizia Caldirola , Ulf Bremberg , Gary Johansson , Andrew Mott , Annika Jenmalm Jensen , Katarina Beierlien , Markus Thor , Lars Tedenborg
IPC分类号: A61P25/00 , A61K31/55 , A61K31/495 , A61K31/50 , A61K31/4965 , A61K31/445 , A61K31/40 , C07D243/08 , C07D241/00 , C07D211/06 , C07D487/00
CPC分类号: C07D295/096 , A61K31/495 , A61K31/4965 , C07D215/38 , C07D215/40 , C07D217/22 , C07D241/04 , C07D243/08 , C07D295/135 , C07D307/78 , C07D307/79 , C07D319/18 , C07D333/34 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08
摘要: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
摘要翻译: 本发明涉及通式(I)的取代磺酰胺化合物,其中P是磺酰胺或酰胺取代的磺酸,该化合物潜在地用于预防和治疗与肥胖,II型糖尿病和/或 中枢神经系统疾病。
-
公开(公告)号:US20070066600A1
公开(公告)日:2007-03-22
申请号:US11510324
申请日:2006-08-25
申请人: Patrizia Caldirola , Ulf Bremberg , Gary Johansson , Andrew Mott , Annika Jensen , Katarina Beierlien , Markus Thor , Lars Tedenborg
发明人: Patrizia Caldirola , Ulf Bremberg , Gary Johansson , Andrew Mott , Annika Jensen , Katarina Beierlien , Markus Thor , Lars Tedenborg
IPC分类号: A61K31/551 , A61K31/496 , A61K31/495 , A61K31/4745 , A61K31/445 , A61K31/4709
CPC分类号: C07D295/096 , A61K31/495 , A61K31/4965 , C07D215/38 , C07D215/40 , C07D217/22 , C07D241/04 , C07D243/08 , C07D295/135 , C07D307/78 , C07D307/79 , C07D319/18 , C07D333/34 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08
摘要: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
摘要翻译: 本发明涉及通式(I)的取代磺酰胺化合物,其中P是磺酰胺或酰胺取代的磺酸,该化合物潜在地用于预防和治疗与肥胖,II型糖尿病和/或 中枢神经系统疾病。
-
-